Survival and cause of death in patients with refractory anemias.

医学 内科学 危险系数 比例危险模型 骨髓增生异常综合症 入射(几何) 人口 胃肠病学 单变量分析 流行病学 生存分析 白血病 多元分析 置信区间 骨髓 物理 光学 环境卫生
作者
Yue Zhang,Bonnie Gould Rothberg,Daniel Morgensztern
出处
期刊:Journal of Clinical Oncology [Lippincott Williams & Wilkins]
卷期号:31 (15_suppl): 7033-7033
标识
DOI:10.1200/jco.2013.31.15_suppl.7033
摘要

7033 Background: Despite its common occurrence, there are few large population-based studies on low-grade myelodysplastic syndromes (MDS). We evaluated the outcomes for the two low-risk MDS subtypes. Methods: The Surveillance, Epidemiology and End Results (SEER) database was searched for patients with refractory anemia (RA) or RA with ringed sideroblasts (RARS), diagnosed between 2001 and 2009 with complete demographic information. Incidence rates were calculated from SEERStat 7.1. Overall survival (OS) and disease-specific survival (DSS) were calculated from diagnosis to death from any cause and death from MDS or acute leukemia, respectively. Univariate survival was estimated by the Kaplan-Meier method and curves compared by log rank. Univariate and multivariable Hazard ratios (HR) were calculated by Cox Proportional Hazards. Results: Among the 6,505 patients who met the inclusion criteria, there were 3,866 (59%) RA and 2,639 (41%) RARS. Age-adjusted incidence rates per 100,000 population for RA and RARS were 0.55 and 0.44 respectively. Medians OS for RA and RARS were 39 and 48 months respectively. Although RARS was associated with improved 5-year OS compared to RA (41.3% vs 37.7%; HR 0.86; 95% CI 0.81-0.92, p < 0.0001), there were no differences in 5-year DSS (74.2% vs 76.3%; HR 1.01, 95% CI 0.90-1.14, p = 0.41). Altogether, 2,112 deaths were accrued among RA patients and 1,352 among the RARS subclass. The number of deaths due to MDS or acute leukemia were 610 (28.8%) in RA and 457 (33.8%) in RARS. Acute leukemia was the cause of death in 190 (9.0%) RA patients and in 143 (10.6%) of RARS patients. Cardiovascular disease accounted for 25% of total deaths in RA and RARS. After adjusted for age, gender, race and year of diagnosis, RARS was associated with increased OS (HR 0.81; 0.76-0.87; p < 0.0001) but not DSS (HR 0.95; 0.84-1.07, p = 0.41). Conclusions: Both RA and RARS are indolent diseases with a high 5-year DSS and death occurring mostly from other causes, particularly cardiovascular disease. Although RARS was associated with better 5-year OS compared to RA, there were no differences in 5-year DSS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
wwww发布了新的文献求助10
刚刚
长夜阶前发布了新的文献求助10
1秒前
1秒前
ndj完成签到,获得积分20
2秒前
2秒前
2秒前
2秒前
3秒前
李爱国的应助被MMLi采纳,获得10
3秒前
Alice发布了新的文献求助10
4秒前
4秒前
汉堡包的应助被梦里格斗家采纳,获得10
5秒前
5秒前
LI发布了新的文献求助10
5秒前
开放访天发布了新的文献求助10
5秒前
虚心求学发布了新的文献求助10
5秒前
钱建栋发布了新的文献求助10
5秒前
小春卷完成签到,获得积分10
6秒前
6秒前
6秒前
研友_VZG7GZ的应助被科研通管家采纳,获得10
6秒前
我是老大的应助被科研通管家采纳,获得10
6秒前
传奇3的应助被科研通管家采纳,获得10
6秒前
招财进宝发布了新的文献求助10
6秒前
6秒前
酷波er的应助被科研通管家采纳,获得10
6秒前
科研通AI2S的应助被科研通管家采纳,获得10
6秒前
领导范儿的应助被科研通管家采纳,获得10
7秒前
美酶桑内发布了新的文献求助10
7秒前
遇到困难睡大觉关注了科研通微信公众号
7秒前
心灵美盼烟完成签到,获得积分10
7秒前
田T完成签到,获得积分10
7秒前
傲娇若南完成签到,获得积分10
7秒前
风吹麦浪发布了新的文献求助10
7秒前
今后的应助被科研通管家采纳,获得10
8秒前
风吹麦浪发布了新的文献求助30
8秒前
8秒前
风吹麦浪发布了新的文献求助10
8秒前
orixero的应助被科研通管家采纳,获得10
8秒前
8秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8193729
求助须知:如何正确求助?哪些是违规求助? 9579876
关于积分的说明 21868333
捐赠科研通 7793519
什么是DOI,文献DOI怎么找? 3437414
关于科研通互助平台的介绍 2560856
邀请新用户注册赠送积分活动 2484216